000 | 01865 a2200517 4500 | ||
---|---|---|---|
005 | 20250515225825.0 | ||
264 | 0 | _c20110120 | |
008 | 201101s 0 0 eng d | ||
022 | _a1873-7064 | ||
024 | 7 |
_a10.1016/j.neuropharm.2010.05.012 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aHandforth, Adrian | |
245 | 0 | 0 |
_aT-type calcium channel antagonists suppress tremor in two mouse models of essential tremor. _h[electronic resource] |
260 |
_bNeuropharmacology _cNov 2010 |
||
300 |
_a380-7 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S. | ||
650 | 0 | 4 | _aAnalysis of Variance |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aBenzimidazoles _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channel Blockers _xtherapeutic use |
650 | 0 | 4 |
_aCalcium Channels, T-Type _xmetabolism |
650 | 0 | 4 |
_aCyclopropanes _xtherapeutic use |
650 | 0 | 4 | _aDisease Models, Animal |
650 | 0 | 4 |
_aEssential Tremor _xchemically induced |
650 | 0 | 4 |
_aEstranes _xtherapeutic use |
650 | 0 | 4 |
_aEthosuximide _xtherapeutic use |
650 | 0 | 4 | _aHarmaline |
650 | 0 | 4 |
_aIsoxazoles _xtherapeutic use |
650 | 0 | 4 | _aMale |
650 | 0 | 4 | _aMice |
650 | 0 | 4 | _aMice, Inbred ICR |
650 | 0 | 4 | _aMice, Knockout |
650 | 0 | 4 |
_aNaphthalenes _xtherapeutic use |
650 | 0 | 4 |
_aNitriles _xtherapeutic use |
650 | 0 | 4 |
_aReceptors, GABA-A _xmetabolism |
650 | 0 | 4 | _aZonisamide |
700 | 1 | _aHomanics, Gregg E | |
700 | 1 | _aCovey, Douglas F | |
700 | 1 | _aKrishnan, Kathiresan | |
700 | 1 | _aLee, Jae Yeol | |
700 | 1 | _aSakimura, Kenji | |
700 | 1 | _aMartin, Fredricka C | |
700 | 1 | _aQuesada, Arnulfo | |
773 | 0 |
_tNeuropharmacology _gvol. 59 _gno. 6 _gp. 380-7 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.neuropharm.2010.05.012 _zAvailable from publisher's website |
999 |
_c19896710 _d19896710 |